Insider transactions

EDGAR

OCUGEN, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
1 transactions, 21,000 shares
Sum of shares × price per share: 25,830
Open-market sales (code S)
4 transactions, 1,051,982 shares
Sum of shares × price per share: 1,088,801.37

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–20 of 20

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-09 Filed 2026-10-13Musunuri Shankar Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)468,7270.95
445,290.65

Derived: shares × price per share. Exact value 445290.65.

4,018,470Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026
  • F2 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001628280-26-065797 Read from the filing’s XML Dispute this row
2026-10-09 Filed 2026-10-13Musunuri Shankar Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)57,2640.95
54,400.8

Derived: shares × price per share. Exact value 54400.80.

1,030,771Indirect (I) By: KVM Holdings, LLCYes
F1, F3, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026
  • F3 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $0.90 to $0.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  • F4 The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
Open filing 0001628280-26-065797 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Musunuri Shankar Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)468,7271.12
524,974.24

Derived: shares × price per share. Exact value 524974.24.

4,487,197Direct (D) Yes
F1, F2
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026
  • F2 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.06 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Open filing 0001628280-26-061626 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Musunuri Shankar Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)57,2641.12
64,135.68

Derived: shares × price per share. Exact value 64135.68.

1,088,035Indirect (I) By: KVM Holdings, LLCYes
F1, F3, F4
  • F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026
  • F3 The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $1.11 to $1.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote (3) to this Form 4.
  • F4 The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
Open filing 0001628280-26-061626 Read from the filing’s XML Dispute this row
2026-06-15 Filed 2026-06-17Johnson-Greene Treerita Essalima Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)21,0001.23
25,830

Derived: shares × price per share. Exact value 25830.00.

521,000Direct (D) No— Open filing 0001628280-26-043886 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-15Kompella Uday Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (170,100) — exercise price 1.22
Acquired (A)170,1000—170,100Direct (D) No
F1
  • F1 The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001104659-26-074078 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-15Chandrasekhar Satishchandran Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (170,100) — exercise price 1.22
Acquired (A)170,1000—170,100Direct (D) No
F1
  • F1 The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001104659-26-074076 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-15Castillo Kirsten Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (170,100) — exercise price 1.22
Acquired (A)170,1000—170,100Direct (D) No
F1
  • F1 The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001104659-26-074073 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-15Coleman Blaise Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (170,100) — exercise price 1.22
Acquired (A)170,1000—170,100Direct (D) No
F1
  • F1 The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001104659-26-074064 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-15Zhang Junge Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (170,100) — exercise price 1.22
Acquired (A)170,1000—170,100Direct (D) No
F1
  • F1 The option vests upon the earlier of (a) June 11, 2027 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.
Open filing 0001104659-26-074072 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,0000.51
7,650

Derived: shares × price per share. Exact value 7650.00.

1,180,182Direct (D) No— Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)112,2050.46
51,614.3

Derived: shares × price per share. Exact value 51614.30.

1,292,387Direct (D) No— Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)66,9291.42
95,039.18

Derived: shares × price per share. Exact value 95039.18.

1,359,316Direct (D) No— Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option (right to buy) — underlying Common Stock (15,000) — exercise price 0.51
Disposed (D)15,0000—0Direct (D) No
F1
  • F1 The option, initially representing a right to purchase 54,000 shares, vested and became exercisable in equal installments over three years commencing on January 2, 2020.
Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option (right to buy) — underlying Common Stock (112,205) — exercise price 0.46
Disposed (D)112,2050—0Direct (D) No
F2
  • F2 The option, representing a right to purchase 112,205 shares, vested and became exercisable on June 9, 2024.
Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-04-01 Filed 2026-04-02Zhang Junge Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option (right to buy) — underlying Common Stock (66,929) — exercise price 1.42
Disposed (D)66,9290—0Direct (D) No
F3
  • F3 The option, representing a right to purchase 66,929 shares, vested and became exercisable on June 28, 2025.
Open filing 0001104659-26-039361 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-06Musunuri Shankar Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,123,2010—4,955,924Direct (D) No
F1
  • F1 Reflects a grant of performance stock units (PSUs). Each PSU represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain performance goals, subject to continued service with the Issuer on the applicable vesting dates.
Open filing 0001470831-26-000020 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-06Musunuri Shankar Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy) — underlying Common Stock (3,123,201) — exercise price 1.38
Acquired (A)3,123,2010—3,123,201Direct (D) No
F3
  • F3 The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.
Open filing 0001470831-26-000020 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-06Ramachandran Ramesh Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)207,3000—209,100Direct (D) No
F1
  • F1 Reflects the grant of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest annually in three equal installments commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.
Open filing 0001470831-26-000019 Read from the filing’s XML Dispute this row
2026-01-02 Filed 2026-01-06Ramachandran Ramesh Officer: Chief Accounting Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Option (Right to Buy) — underlying Common Stock (310,950) — exercise price 1.38
Acquired (A)310,9500—310,950Direct (D) No
F2
  • F2 The option vests annually in equal installments over three years commencing on January 2, 2027, subject to continued service with the Issuer on the applicable vesting dates.
Open filing 0001470831-26-000019 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Christopher L. Jacobs (NY27)2022-11-08Sale$1,001 - $15,0002022-12-12
Hon. Christopher L. Jacobs (NY27)2022-06-16Purchase$15,001 - $50,0002022-07-28

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
JANUS HENDERSON GROUP Ltd. Common Stock3.010,000,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001274173-26-000196 Dispute this row
STATE STREET CORPORATION COMMON STOCK6.321,469,307.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000513 Dispute this row
BlackRock, Inc. Common Stock8.026,952,49206/30/2026 Filed 2026-07-29SCHEDULE 13GOpen filing 0002012383-26-002838 Dispute this row
Millennium Management LLC Common Stock, par value $0.01 per share5.217,074,584.0004/09/2026 Filed 2026-04-14SCHEDULE 13GOpen filing 0001104659-26-043361 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.01 per share5.217,074,584.0004/09/2026 Filed 2026-04-14SCHEDULE 13GOpen filing 0001104659-26-043361 Dispute this row
Israel A. Englander Common Stock, par value $0.01 per share5.217,074,584.0004/09/2026 Filed 2026-04-14SCHEDULE 13GOpen filing 0001104659-26-043361 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-001913 Dispute this row
The Vanguard Group Common Stock5.2716,475,56212/31/2025 Filed 2026-01-30SCHEDULE 13GOpen filing 0000102909-26-000152 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock6.020,000,00011/28/2025 Filed 2025-12-08SCHEDULE 13GOpen filing 0001274173-25-000339 Dispute this row
The Vanguard Group Common Stock4.8715,223,58509/30/2025 Filed 2025-10-31SCHEDULE 13G/AAmendment 2Open filing 0000102909-25-000248 Dispute this row
BlackRock, Inc. Common Stock1.95,522,30206/30/2025 Filed 2025-07-17SCHEDULE 13G/AAmendment 1Open filing 0002052113-25-003100 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,556,900 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020183,193
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to OCUGEN, INC.